600664 哈药股份
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.6738.73311.38010.129-24.120
总资产报酬率 ROA (%)1.2512.8703.5403.006-8.852
投入资产回报率 ROIC (%)2.0374.7745.9495.068-15.179

边际利润分析
销售毛利率 (%)28.40526.21424.66623.71521.759
营业利润率 (%)5.9184.2685.0395.018-8.733
息税前利润/营业总收入 (%)5.9954.3885.5675.668-8.510
净利润/营业总收入 (%)4.5943.0683.7093.201-9.689

收益指标分析
经营活动净收益/利润总额(%)92.32099.74275.19065.96975.838
价值变动净收益/利润总额(%)0.0000.6895.7510.135-3.653
营业外收支净额/利润总额(%)-0.021-1.3970.763-1.8842.740

偿债能力分析
流动比率 (X)1.2951.2611.1951.1121.069
速动比率 (X)1.0611.0280.9690.8490.814
资产负债率 (%)60.32261.57363.18165.57966.334
带息债务/全部投入资本 (%)39.39740.23139.95742.922--
股东权益/带息债务 (%)142.056136.601136.023116.798116.937
股东权益/负债合计 (%)57.43054.36750.98545.68144.276
利息保障倍数 (X)76.91824.47211.3717.632-18.177

营运能力分析
应收账款周转天数 (天)99.39899.228104.846105.9100.000
存货周转天数 (天)58.02658.84566.92872.3520.000